Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
101.8 USD | -0.88% | -4.03% | +10.95% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.95% | 6.43B | |
+64.72% | 62.59B | |
-1.45% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.33% | 26.21B | |
-21.80% | 19.09B | |
+4.96% | 13.08B | |
+25.47% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- SVB Securities Adjusts Price Target on Blueprint Medicines to $48 From $45, Maintains Market Perform Rating